|Articles|August 26, 2010

Regulatory Roundup: PDUFA Fees Published, And More.

Regulatory Roundup: PDUFA Fees Published, And More.

The US Food and Drug Administration announced last week that it mailed invoices for product and establishment fees as part of the Prescription Drug User Fee Act (PDUFA). Payments are due Oct. 1, 2010. PDUFA, originally enacted in 1992, authorizes FDA to collect fees from companies that produce certain human drug and biological products. User fees help to expedite the drug approval process. The rates for fiscal year 2011 are posted here.

According to new data released by the US Centers for Disease Control and Prevention (CDC), vaccinations among teenagers (ages 13 to 17) are on the rise. Coverage for this age group increased 15% according to the 2009 National Immunization Survey-Teen (NIS-Teen) results, which included more than 20,000 teens and was conducted by CDC. Among vaccines on the rise are: tetanus-diphtheria-acellular pertussis, meningococcal conjugate, and human papillomavirus (one dose as compared to three doses). "This year's data are mixed," said Anne Schuchat, MD, director of CDC's National Center for Immunization and Respiratory Diseases in the press release about the study. "We can see that more parents of adolescents are electing to protect their children from serious diseases such as pertussis, meningitis, and cervical cancer, but there is clear room for improvement in our system's ability to reach this age group."


Related to this article

Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.